Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, POL, AVO

Savings Behind President Trump's Executive Order Lowering Prescription Drug Prices Through Personal Importation

WASHINGTON, July 28, 2020 /PRNewswire/ -- The Campaign for Personal Prescription Importation (CPPI) released the below statement following President Donald J. Trump's signing of an executive order giving Americans access personally import safe and access affordable medicines from abroad.

"Americans' need for affordable prescription drugs has never been greater then it is right now amid the Coronavirus pandemic. President Trump's executive order rightly opens the door for Americans' to access safe prescription drugs through accredited Canadian pharmacies. These pharmacies provide medicines at a fraction of the price that consumers pay for the same medicines in the U.S.," said Jack Pfeiffer, executive director of the Campaign for Personal Prescription Importation.

"While federal legislation has been evasive, for years millions of Americans have turned to personal prescription importation from licensed Canadian pharmacies as prices in the U.S. soared."

Full Text of Executive Order on Increasing Drug Importation to Lower Prices for American Patients

Savings Behind Personal Prescription Importation from Online Canadian Pharmacies

A CPPI Personal Prescription Importation Survey released July 13, 2020, highlights the incredible savings that Americans can access through personal prescription importation:

Taking Advantage of Personal Prescription Importation Savings

Over 2.4 million Americans have been importing prescription drugs from foreign countries for years. The new Executive Order, further eases restrictions and clarifies the U.S. government's support for the practice of personal prescription importation. Americans do not need to wait to take advantage of the incredible savings, they can take these easy steps now:

About the Campaign for Personal Prescription Importation
The Campaign for Personal Prescription Importation (CPPI) is a national nonprofit patient advocacy organization that fights for Americans' access to safe, affordable prescription medications from Canada for personal use. Tens of millions of Americans ? especially the elderly and others on fixed incomes ? struggle to pay the extremely high price of prescription medications in the U.S. We are here to be their voice.

Hundreds of thousands of Americans use licensed Canadian pharmacies annually, to purchase their daily prescription medications at an affordable price. We believe that all Americans have a right to affordable medications. It is time to change the current U.S. policy on this issue to provide immediate access to life-saving medications, taken daily for chronic health conditions, at affordable prices.

SOURCE Campaign for Personal Prescription Importation

These press releases may also interest you

at 23:00
The live music market is expected to grow by USD 2.83 billion during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of COVID-19 pandemic on the live music market in optimistic, probable, and pessimistic...

at 23:00
BioVaxys Technology Corp. ("BioVaxys" or the "Company") is pleased to announce that it has closed the second and final tranche of its previously announced non-brokered private placement (the "Private Placement")....

at 22:40
BECLE, S.A.B. de C.V. ("Cuervo", "Becle" or the "Company") (BMV: CUERVO) today announced financial results for the quarter ended June 30th, 2021. All figures in this release are derived from the Company's interim consolidated financial statements as...

at 22:30
Technavio has been monitoring the organic soap market and it is poised to grow by USD 260.23 million during 2020-2024, progressing at a CAGR of 6% during the forecast period. The report offers an up-to-date analysis regarding the current market...

at 22:15
Icosavax, Inc. , a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases, today announced the...

at 22:00
The global well abandonment services market is poised to grow by USD 1.09 bn during 2020-2024, progressing at a CAGR of over 5% during the forecast period....

News published on 28 july 2020 at 11:45 and distributed by: